Cancer Australia
Australia (Commonwealth) · 1 open tender · contract awards since 5 November 2023
- contract awards
- 255
- middle half of values, AUD
- 22,000 to 163,905
- end within 12 months
- 51
Not a price guide.
Contract awards by year published
2026: 76 contract awards, AUD 9,342,584 as published. The latest 5 are shown.
| Contract | Published | Ends | Value (AUD) |
|---|---|---|---|
SAP Concur software subscription | 2 Nov 2026 | 1 Dec 2027 | 30,357 |
Fees for 12 months membership of a Cross Tasman Executive Learning Set program | 26 Oct 2026 | 29 Jun 2027 | 12,045 |
Contract with Nous Group Pty Ltd and partner Curijo to provide services to implement the Monitoring and Evaluation Framework for the Partnerships for culturally safe cancer care grant program. | 23 Oct 2026 | 30 Jun 2028 | 693,629 |
Development of guidance on research priorities for the Low Survival Cancers Mission | 22 Oct 2026 | 31 Mar 2027 | 62,700 |
Comparative toxicity and economic analyses of proton beam therapy | 20 Oct 2026 | 6 Nov 2026 | 68,537 |
The latest 5 of 76 are shown.
Values as published. Not a price guide. Holders’ names need a sign-in.
Contracts ending in the next 12 months
Each bar is a calendar month. Violet: this month and the next two.
Nov 2026: 4 contracts end. The first 3 are shown, soonest first.
| Contract | Ends | Value (AUD) |
|---|---|---|
Comparative toxicity and economic analyses of proton beam therapy | 6 Nov 2026 | 68,537 |
Sponsorship of Congress of Aboriginal and Torres Strait Islander Nurses and Midwives conference 2026 | 19 Nov 2026 | 25,000 |
Cancer Australia has engaged ORIMA Research to deliver the fourth national audit of cancer research funding and key funding drivers report, by undertaking an audit of cancer research funding across the period of 2021-2023 combined with a desktop review and analysis of the key drivers for cancer research patterns and funding over this period. | 21 Nov 2026 | 190,784 |
1 more ends this month.
End dates as published; options to extend are not commitments. Sign in to see who holds these contracts.
Open now
| Tender | Closes |
|---|---|
| Digital and AI Transformation | 17 Nov 2026 |
Planned procurements
| Plan | Window |
|---|---|
| National Cancer Clinical Quality Indicators | Jan to Mar 2027 |
Who wins this buyer's work
| Supplier | Share of contracts | Contracts |
|---|---|---|
| Largest | 2.7% | 7 |
| Second | 2.3% | 6 |
| Third | 2.3% | 6 |
| 4th | 1.9% | 5 |
| 5th | 1.9% | 5 |
| 6th | 1.9% | 5 |
| 7th | 1.6% | 4 |
| 8th | 1.6% | 4 |
| 9th | 1.6% | 4 |
| 10th | 1.6% | 4 |
One row per buyer name as published; a department listed under two spellings is two buyers here, never merged. Values are the published amount and currency.